Research location
Handan
Hebei, China
Advertisement
Research activity in Handan
Hebei, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 16 trials and 17 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Handan
16 linked trials · page 1 of 1A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast CancerNCT07673029 · 2025-01-10 · 1 site observation
RECRUITING
The Chinese Familial Alzheimer's NetworkNCT03657732 · 2005-01-10 · 1 site observation
RECRUITING
China Cognition and Aging StudyNCT03653156 · 2000-01-01 · 1 site observation
RECRUITING
A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)NCT07812597 · 2026-10-12 · 1 site observation
NOT_YET_RECRUITING
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)NCT07230119 · 2026-01-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of ZT006 in Overweight and Obese ParticipantsNCT07230132 · 2025-12-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High RiskNCT07010588 · 2025-06-01 · 1 site observation
NOT_YET_RECRUITING
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese SubjectsNCT06738979 · 2025-03-20 · 1 site observation
COMPLETED
A Study of ZT002 Injection With Subjects With Overweight or ObesityNCT07020884 · 2024-08-14 · 1 site observation
COMPLETED
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 DiabetesNCT06350890 · 2023-11-05 · 1 site observation
COMPLETED
China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)NCT05221580 · 2022-03-18 · 1 site observation
COMPLETED
Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes MellitusNCT05102149 · 2021-09-30 · 1 site observation
UNKNOWN
Circulating Tumor Cells Screen for Breast CancerNCT05633680 · 2020-02-20 · 1 site observation
UNKNOWN
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 DiabetesNCT04109547 · 2019-10-01 · 1 site observation
COMPLETED
Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.NCT03388593 · 2018-07-23 · 2 site observations
UNKNOWN
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer PatientsNCT02221999 · 2013-09-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.